The development of oral dosage forms for clinical trials presents a unique set of challenges, particularly in early phases of ...

TriNetX is using real world data to reduce clinical trial enrollment time by as much as 40 percent2. Artificial intelligence ...

Biogen Inc. (Nasdaq: BIIB) and City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today ...

the panel recommended that Health Canada make it possible for people in Canada to access health products containing cannabis through standard drug approval pathways. The panel also recommended that ...

Adapting to uncertainty over product review timelines at FDA could complicate M&A for pharma buyers and sellers, especially ...

At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...